OUR PRODUCTS

MOBILE APPS

GENERAL INFO

TSHA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Taysha Gene Therapies (TSHA) Earnings Date & Reports

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TSHA is expected to report earnings to fall 10.89% to -8 cents per share on November 12

Taysha Gene Therapies TSHA Stock Earnings Reports

Q3'25

Est.

$-0.08

Q2'25

Missed

by $0.01

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.01

The last earnings report on August 12 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 2.89M shares outstanding, the current market capitalization sits at 802.02M.

View a ticker or compare two or three

Compare

TSHA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TSHA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TSHA showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3000 Pegasus Park Drive

Phone

+1 214 612-0000

Employees

Web

https://www.tayshagtx.com